异动解读 | 外资连续3天减持加上新项目研发投入增加 令君实生物股价盘中大跌5.08%

异动解读
22 Nov 2024

生物医药行业龙头股君实生物(01877)今日盘中出现大幅波动,出现下跌5.08%的剧烈跳水。据最新消息,这与外资连续减持以及公司加大新药研发投入两方面因素密切相关。

从资金流向来看,南向资金连续3天净卖出君实生物股票,仅昨日就减持6.22万股,显示外资正加快离场步伐。外资持续撤离无疑给股价带来极大压力。

与此同时,君实生物近日宣布与国外医药公司签署新的许可协议,获得两款双靶点融合蛋白的大中华区开发权利。这意味着公司未来需投入更多资金用于新药研发,进一步加重公司资金压力。投资者纷纷对公司前景表示担忧,加剧了股价下跌行情。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10